GSK moving some clinical trials to low-cost countries

11/2/2004 | Guardian (London), The

GlaxoSmithKline announced plans to move 30% of its clinical trials to low-cost countries in the Far East and Eastern Europe over the next two years. GSK reportedly faces higher research costs because of the number of clinical trials planned, and at the same time has lost sales to generics. In countries such as India, the cost of conducting clinical trials can be only 10% of the costs in the West.

View Full Article in:

Guardian (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Associate Manager, Regulatory Affairs
Stryker
Mahwah, NJ
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC